| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 128.77M | 94.54M | 63.71M | 58.71M | 63.14M | 55.83M |
| Gross Profit | 62.30M | 39.55M | 14.05M | 7.87M | 19.33M | 16.54M |
| EBITDA | 61.82M | 37.22M | 15.15M | 9.21M | 19.48M | 15.23M |
| Net Income | 44.90M | 27.82M | 6.58M | -983.05K | 9.95M | 7.03M |
Balance Sheet | ||||||
| Total Assets | 182.64M | 124.90M | 115.25M | 100.24M | 90.68M | 76.24M |
| Cash, Cash Equivalents and Short-Term Investments | 38.77M | 22.18M | 11.55M | 7.20M | 12.22M | 6.60M |
| Total Debt | 6.44M | 5.95M | 6.55M | 6.95M | 735.01K | 9.08M |
| Total Liabilities | 28.33M | 20.72M | 22.45M | 18.71M | 10.79M | 18.49M |
| Stockholders Equity | 154.31M | 104.18M | 92.79M | 81.52M | 79.89M | 57.75M |
Cash Flow | ||||||
| Free Cash Flow | 17.84M | 11.93M | 4.72M | -9.31M | -3.30M | 4.67M |
| Operating Cash Flow | 46.09M | 30.88M | 12.09M | 1.96M | 14.80M | 14.56M |
| Investing Cash Flow | -27.06M | -18.39M | -6.74M | -10.96M | -23.21M | -15.76M |
| Financing Cash Flow | -624.96K | -885.34K | -1.27M | 3.89M | 14.24M | -5.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £336.20M | 2.17 | 40.73% | ― | 61.98% | 164.33% | |
73 Outperform | £225.69M | 4.30 | 34.96% | ― | 44.89% | 120.82% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | £49.14M | 57.47 | 5.02% | ― | ― | ― | |
50 Neutral | £132.11M | -2.70 | -10.90% | ― | ― | ― | |
47 Neutral | £257.27M | 13.71 | -12.56% | ― | 129.53% | 70.68% |